Volume | 189,761 |
|
|||||
News | - | ||||||
Day High | 296.00 | Low High |
|||||
Day Low | 290.855 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Bio Rad Laboratories Inc | BIO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
296.00 | 290.855 | 296.00 | 293.85 | 295.73 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
7,913 | 189,761 | $ 294.08 | $ 55,804,784 | - | 261.59 - 431.79 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:30:00 | 29,420 | $ 293.85 | USD |
Bio Rad Laboratories Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.98B | 28.52M | - | 2.67B | -637.32M | -22.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Bio Rad Laboratories News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 279.06 | 302.71 | 277.785 | 291.74 | 216,452 | 14.79 | 5.30% |
1 Month | 283.12 | 302.71 | 266.52 | 280.59 | 227,952 | 10.73 | 3.79% |
3 Months | 340.60 | 360.13 | 266.52 | 309.96 | 203,845 | -46.75 | -13.73% |
6 Months | 308.14 | 364.24 | 266.52 | 313.75 | 221,683 | -14.29 | -4.64% |
1 Year | 384.82 | 431.79 | 261.59 | 335.42 | 224,226 | -90.97 | -23.64% |
3 Years | 597.34 | 832.70 | 261.59 | 460.06 | 190,682 | -303.49 | -50.81% |
5 Years | 296.21 | 832.70 | 261.59 | 455.20 | 200,038 | -2.36 | -0.80% |
Bio Rad Laboratories Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier. |